EYEGATE PHARMACEUTICALS INC (18)

Browse by Contract Category

Contracts

Registration Rights Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of January 5, 2021 (Filed With SEC on January 6, 2021)
Employment Agreement by and between EyeGate Pharmaceuticals, Inc. and Sarah Romano, dated as of March 23, 2020 (Filed With SEC on March 24, 2020)
Amendment No. 1 to Sub-License Agreement, dated as of September 18, 2015, by and between Jade Therapeutics, Inc. and Biotime, Inc (Filed With SEC on March 4, 2020)
Securities Purchase Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of January 5, 2021 (Filed With SEC on January 6, 2021)
Form of Warrant (Filed With SEC on January 6, 2021)
Registration Rights Agreement, dated as of December 18, 2020, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein (Filed With SEC on December 21, 2020)
Share Purchase Agreement, dated as of December 18, 2020, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein (Filed With SEC on December 21, 2020)
Amendment No. 2 to Sub-License Agreement, dated as of February 17, 2016, by and between Jade Therapeutics, Inc. and Biotime, Inc (Filed With SEC on March 4, 2020)
Exclusive Sub-License Agreement, dated as of September 12, 2013, by and between Jade Therapeutics, Inc. and Biotime, Inc (Filed With SEC on March 4, 2020)
Description of Securities (Filed With SEC on March 4, 2020)
Engagement Letter between EyeGate Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC, dated as of December 30, 2019 (Filed With SEC on December 31, 2019)
Form of Securities Purchase Agreement (Filed With SEC on December 31, 2019)
Form of Placement Agent Warrant (Filed With SEC on December 31, 2019)
Amendment to Third Amended and Restated Employment Agreement by and between EyeGate Pharmaceuticals, Inc. and Stephen From, dated as of November 26, 2019 (Filed With SEC on December 3, 2019)
EyeGate Pharmaceuticals, Inc. Amended and Restated Change in Control Severance Plan (Filed With SEC on December 3, 2019)
Securities Purchase Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of September 29, 2019 (Filed With SEC on September 30, 2019)
Registration Rights Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of September 29, 2019 (Filed With SEC on September 30, 2019)
Form of Warrant (Filed With SEC on September 30, 2019)